AAIC 2025 Abstract
Using NULISAseq to identify biomarkers linked to postmortem Alzheimer's disease and other neurodegenerative pathologies
Study in peopleBiomarkers
Abstract
Background: Plasma biomarkers are increasingly recognized for identifying Alzheimer's disease (AD) pathology but biomarkers for other common co‐occurring pathologies ( e.g ., TDP‐43, alpha‐synuclein) are needed.
